Treatment options for latent tuberculosis infection
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Treatment options for latent tuberculosis infection
  • Published Date:

    November 2011

  • Source:
    TB elimination
  • Language:
    English
Filetype[PDF-195.72 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.30 MB]
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    August 2016
    Series:
    TB elimination
    Description:
    Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminatingTB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. The Centers for Disease Control and Pr...
    File Type:
    Filetype[PDF - 1.30 MB]
  2. Filetype[PDF - 1.03 MB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    4/4/17
    Description:
    The purpose of this toolkit is to assist TB programs in developing and implementing a TB eDOT program. There are a wide variety of eDOT programs throughout the United States. These eDOT programs have been designed to meet their respective TB programâ...
    File Type:
    Filetype[PDF - 1.03 MB]
  3. Filetype[PDF - 1.59 MB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/28/13
    Series:
    HAN ; 340
    Description:
    January 28, 2013, 09:00 ETCDCHAN-00340Recommendations for drug allocation, tuberculosis prevention, and patient care during isoniazid shortages Summary: Shortages of isoniazid (INH), a cornerstone drug for treating tuberculosis disease (TB) and laten...
    File Type:
    Filetype[PDF - 1.59 MB]
  4. Filetype[PDF - 511.83 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.)
    Published Date:
    12/12/13
    Description:
    Proteja a su familia y amigos de la tuberculosis: ¡tómese todos sus medicamentos para la tuberculosis!CS244103-BPublications date for document properties.
    File Type:
    Filetype[PDF - 511.83 KB]
  5. Filetype[PDF - 155.65 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.)
    Published Date:
    6/21/18
    Description:
    CS292653BPublication date from document properties.LTBI_Medication_Tracker.pdf
    File Type:
    Filetype[PDF - 155.65 KB]